✦ LIBER ✦

Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome

✍ Scribed by S. Mendizábal; I. Zamora; O. Berbel; M. J. Sanahuja; J. Fuentes; J. Simon

Publisher: Springer
Year: 2005
Tongue: English
Weight: 140 KB
Volume: 20
Category: Article
ISSN: 0931-041X
DOI: 10.1007/s00467-005-1877-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of mycophenolate mofetil in steroid-

Use of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndrome

✍ Gina-Marie Barletta; William E. Smoyer; Timothy E. Bunchman; Joseph T. Flynn; Da 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 146 KB

Mycophenolate mofetil in children with s

Mycophenolate mofetil in children with steroid/cyclophosphamide-resistant nephrotic syndrome

✍ Valderez Raposo de Mello; Maira Tinte Rodrigues; Tais Helena Mastrocinque; Simon 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 138 KB

Mycophenolate mofetil therapy for childr

Mycophenolate mofetil therapy for children with steroid-resistant nephrotic syndrome

✍ Zhihui Li; Cuirong Duan; Jinhua He; Tianhui Wu; Mai Xun; Yi Zhang; Yan Yin 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 112 KB

Treatment with mycophenolate mofetil and

Treatment with mycophenolate mofetil and prednisolone for steroid-dependent nephrotic syndrome

✍ Kamran Afzal; Arvind Bagga; Shina Menon; Pankaj Hari; Stanley C. Jordan 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 132 KB

Efficacy of mycophenolate mofetil in ped

Efficacy of mycophenolate mofetil in pediatric patients with steroid-dependent nephrotic syndrome

✍ Inna Novak; Rachel Frank; Suzanne Vento; Marcela Vergara; Bernard Gauthier; Howa 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 109 KB

Mycophenolate mofetil versus cyclosporin

Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome

✍ Eiske M. Dorresteijn; Joana E. Kist-van Holthe; Elena N. Levtchenko; Jeroen Naut 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 194 KB

We performed a multi-centre randomized controlled trial to compare the efficacy of mycophenolate mofetil (MMF) to that of cyclosporine A (CsA) in treating children with frequently relapsing nephrotic syndrome and biopsy-proven minimal change disease. Of the 31 randomized initially selected patients,